BayBio Welcomes New Board Members.Life Sciences Industry Association Expands Board of Directors to Deliver Broad Agenda SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif. -- BayBio today announced the election of thirteen new executives to its board of directors for 2007. This select group joins BayBio in its on-going effort to serve the life sciences industry in Northern California Northern California, sometimes referred to as NorCal, is the northern portion of the U.S. state of California. The region contains the San Francisco Bay Area, the state capital, Sacramento; as well as the substantial natural beauty of the redwood forests, the northern . "The life sciences industry in Northern California is a bellwether," said Gregg Alton, Chair of the Board and the Senior Vice President and General Counsel of Gilead Sciences Gilead Sciences NASDAQ: GILD is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. . "As the industry matures we face new opportunities and challenges, and in Northern California these leaders can expect to be prime movers in the development of solutions." The new board members for 2007 include Eugene Bauer, Neosil Incorporated; Robert Brigham, Cooley Godward Kronish Cooley Godward Kronish LLP ("Cooley") is a law firm that represents entrepreneurs, venture capitalists, and emerging growth companies in major technology fields. The 600-attorney firm is headquartered in Silicon Valley's Palo Alto with offices in other major technology hubs around LLP LLP - Lower Layer Protocol ; Peter Calcott, PDL See page description language. 1. PDL - Page Description Language. 2. PDL - Program Design Language. 3. PDL - Push Down List. 4. PDL - Dave Lebling, one of the co-authors of Zork. BioPharma, Inc.; Keith Donnermeyer, Deloitte & Touche LLP; Kareem Dossa, VWR International; Paul Hastings, OncoMed Pharmaceuticals; Hoyoung Huh, Nektar Therapeutics; Caroline Loewy, Poniard Pharmaceuticals; Susan Molineaux, Proteolix, Inc.; Antoun Nabhan, Sagamore sag·a·more n. A subordinate chief among the Algonquians of North America. [Eastern Abenaki s Bioventures; Glenn Pierce, Bayer Healthcare; Steve Richardson, Alexandria Real Estate; and Anthony Stolis, Clarkston Consulting. "This is a group of leaders dedicated to advancing a broad agenda on behalf of our industry," added Scott Morrison, Treasurer of the Board and U.S. Life Sciences Director, Ernst & Young. "Their commitment to serve is recognition and reminder that success in life sciences depends upon relationships with the public sector. BayBio serves a central part to us all in strengthening those ties." The BayBio board of directors plays a key role in defining the life sciences industry to public sector partners, advancing an agenda that serves the life sciences industry, and promoting a business climate to support the industry's growth. With the addition of these thirteen new members, the BayBio board of directors has 39 members, of which 26 are executives in life sciences companies, and thirteen of which are employed in key stakeholder organizations, ranging from accounting and law to venture capital and real estate. About BayBio BayBio is Northern California's life sciences industry association. We support the regional life sciences community through advocacy, enterprise support and the enhancement of research collaboration. Our members include organizations engaged in, or supportive of, research, development and commercialization of life science technologies. BayBio is the regional affiliate for Northern California of the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
For more information please visit www.baybio.org or call (650) 871-7101. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion